probenecid has been researched along with haloperidol in 39 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 22 (56.41) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 8 (20.51) | 29.6817 |
2010's | 8 (20.51) | 24.3611 |
2020's | 1 (2.56) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Bellman, K; Knegtel, RM; Settimo, L | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
Scally, MC; Ulus, I; Wurtman, RJ | 1 |
Dedek, J; Gomeni, R; Korf, J | 1 |
Bacopoulos, NG; Heninger, GR; Roth, RH | 1 |
Korf, J; Westerink, BH | 3 |
Korf, J; Sebens, JB | 1 |
Hefti, F | 1 |
Carter, CJ; Pycock, CJ | 1 |
Adams, F; Becker, JB; Robinson, TE | 1 |
Djordjević, N; Jernej, B; Levanat, S; Manev, H; Pericić, D; Vujić, D | 1 |
Kharouba, SN; Kim, C; Speisky, MB | 1 |
Kikkert, RJ; Westerink, BH | 1 |
Chase, TN | 3 |
Gessa, GL; Perez-Cruet, J; Stern, S; Tagliamonte, A; Tagliamonte, P | 1 |
Werdinius, B | 1 |
Bartholini, G; Keller, HH; Pletscher, A | 1 |
Dresse, A; Gérardy, J; Quinaux, N | 1 |
Bowers, MB; Gold, BI; Roth, RH | 1 |
Huot, S; Palfreyman, MG; Wagner, J | 1 |
Emanuelsson, C; Erhardt, S; Geyer, M; Schwieler, L | 1 |
2 review(s) available for probenecid and haloperidol
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Drug-induced extrapyramidal disorders.
Topics: Antiparkinson Agents; Apomorphine; Basal Ganglia Diseases; Benztropine; Dihydroxyphenylalanine; Dopamine; Drug-Related Side Effects and Adverse Reactions; Extrapyramidal Tracts; Haloperidol; Humans; Methyltyrosines; Movement Disorders; Phenothiazines; Phenylacetates; Probenecid; Reserpine; Synaptic Transmission; Tetrabenazine; Tranquilizing Agents; Trihexyphenidyl | 1972 |
37 other study(ies) available for probenecid and haloperidol
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Brain tyrosine level controls striatal dopamine synthesis in haloperidol-treated rats.
Topics: Animals; Brain Chemistry; Corpus Striatum; Dopamine; Drug Interactions; Haloperidol; Homovanillic Acid; Male; Probenecid; Rats; Tyrosine; Tyrosine 3-Monooxygenase | 1977 |
A model of dopamine metabolism in rat brain, assessed by the influence of drugs [proceedings].
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Dopamine; Haloperidol; Homovanillic Acid; Pargyline; Probenecid; Rats | 1979 |
Effects of haloperidol and probenecid on plasma and CSF dopamine metabolites in the rhesus monkey (Macacca mulatta).
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Dopamine; Drug Interactions; Haloperidol; Haplorhini; Homovanillic Acid; Macaca mulatta; Male; Probenecid; Starvation; Time Factors | 1978 |
Influence of drugs on striatal and limbic homovanillic acid concentration in the rat brain.
Topics: Aminooxyacetic Acid; Animals; Atropine; Brain; Brain Chemistry; Clozapine; Corpus Striatum; Fenclonine; Haloperidol; Homovanillic Acid; Limbic System; Male; Morphine; Oxotremorine; Phenylacetates; Physostigmine; Pimozide; Probenecid; Rats; Substantia Nigra; Trihexyphenidyl | 1975 |
Cyclic AMP in cerebrospinal fluid: accumulaiton following probenecid and biogenic amines.
Topics: Animals; Biogenic Amines; Catecholamines; Cyclic AMP; Dopamine; Haloperidol; Histamine; Injections, Intraperitoneal; Injections, Intravenous; Injections, Spinal; Isoproterenol; Levodopa; Male; Norepinephrine; Probenecid; Rabbits; Stimulation, Chemical | 1975 |
A simple, sensitive method for measuring 3,4-dihydroxyphenylacetic acid and homovanillic acid in rat brain tissue using high-performance liquid chromatography with electrochemical detection.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Apomorphine; Brain Chemistry; Chromatography, High Pressure Liquid; Corpus Striatum; Haloperidol; Homovanillic Acid; Male; Phenylacetates; Probenecid; Rats; Tissue Distribution | 1979 |
Potentiation of haloperidol-induced catalepsy by dopamine agonists: possible involvement of central 5-hydroxytryptamine.
Topics: Animals; Apomorphine; Brain; Catalepsy; Dextroamphetamine; Dopamine; Drug Interactions; Haloperidol; Humans; Hydroxyindoleacetic Acid; Male; Probenecid; Rats; Serotonin | 1979 |
Acidic dopamine metabolites in cortical areas of the rat brain: localization and effects of drug.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amphetamine; Animals; Apomorphine; Cerebral Cortex; Clozapine; Corpus Striatum; Haloperidol; Homovanillic Acid; Male; Morphine; Olfactory Bulb; Oxotremorine; Phenylacetates; Probenecid; Rats; Sulpiride; Thioridazine | 1976 |
Comparison of effects of drugs on dopamine metabolism in the substantia nigra and the corpus striatum of rat brain.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Apomorphine; Brain Chemistry; Chloral Hydrate; Corpus Striatum; Dopamine; Haloperidol; Homovanillic Acid; Male; Morphine; Oxotremorine; Pargyline; Phenylacetates; Probenecid; Promethazine; Rats; Receptors, Dopamine; Substantia Nigra | 1976 |
Intraventricular microdialysis: a new method for determining monoamine metabolite concentrations in the cerebrospinal fluid of freely moving rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenal Medulla; Animals; Cerebral Ventricles; Dialysis; Dopamine; Female; Haloperidol; Homovanillic Acid; Hydroxydopamines; Hydroxyindoleacetic Acid; Oxidopamine; Phenylacetates; Probenecid; Rats; Substantia Nigra | 1988 |
Effect of dihydroergosine (DHESN) on the serotoninergic system and behaviour: is DHESN a new antidepressive agent?
Topics: Animals; Antidepressive Agents; Blood Platelets; Cyproheptadine; Ergotamines; Fenclonine; Haloperidol; Male; Monoamine Oxidase Inhibitors; Motor Activity; Probenecid; Rats; Rats, Inbred Strains; Serotonin | 1986 |
Rapid and sensitive method for measuring norepinephrine, dopamine, 5-hydroxytryptamine and their major metabolites in rat brain by high-performance liquid chromatography. Differential effect of probenecid, haloperidol and yohimbine on the concentrations o
Topics: Animals; Biogenic Amines; Biotransformation; Brain Chemistry; Chromatography, High Pressure Liquid; Dopamine; Haloperidol; Hydrolysis; Norepinephrine; Probenecid; Rats; Rats, Inbred Strains; Serotonin; Yohimbine | 1987 |
Effect of various centrally acting drugs on the efflux of dopamine metabolites from the rat brain.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amphetamine; Animals; Biological Transport, Active; Brain; Brain Stem; Central Nervous System Agents; Chloral Hydrate; Chlorpromazine; Corpus Striatum; Dopamine; Frontal Lobe; Haloperidol; Homovanillic Acid; Kainic Acid; Male; Olfactory Bulb; Oxotremorine; Pargyline; Phenylacetates; Probenecid; Rats | 1986 |
Central monoamine metabolism in man. Effect of putative dopamine receptor agonists and antagonists.
Topics: Adult; Basal Ganglia Diseases; Brain; Central Nervous System Diseases; Dopamine; Haloperidol; Homovanillic Acid; Humans; Huntington Disease; Hydroxyindoleacetic Acid; Muscular Diseases; Parkinson Disease; Piperazines; Probenecid; Receptors, Drug; Serotonin | 1973 |
Effect of psychotropic drugs on tryptophan concentration in the rat brain.
Topics: Alkaloids; Animals; Apomorphine; Aporphines; Body Temperature; Brain Chemistry; Butyrates; Chlorpromazine; Cold Temperature; Cyclic AMP; Dextroamphetamine; Fenclonine; Fenfluramine; Haloperidol; Hot Temperature; Hydroxybutyrates; Hydroxyindoleacetic Acid; Lithium; Male; Methyltyrosines; Morphine; Nucleosides; Phenelzine; Phenmetrazine; Probenecid; Rats; Reserpine; Serotonin; Tryptophan; Tyrosine | 1971 |
Effect of probenecid on the level of homovanillic acid in the corpus striatum.
Topics: Animals; Basal Ganglia; Dopamine; Female; Fluorometry; Haloperidol; Male; Phenylacetates; Probenecid; Rats; Reserpine | 1966 |
Clinical studies of dopaminergic mechanisms.
Topics: Antiparkinson Agents; Dioxoles; Dopamine; Drug Evaluation; Haloperidol; Homovanillic Acid; Humans; Levodopa; Parkinson Disease; Piperidines; Probenecid; Pyrimidines | 1974 |
Spontaneous and drug-induced changes of cerebral dopamine turnover during postnatal development of rats.
Topics: Animals; Apomorphine; Brain; Corpus Striatum; Dopamine; Feedback; Female; Haloperidol; Homovanillic Acid; Male; Norepinephrine; Phenylacetates; Probenecid; Rats; Receptors, Adrenergic | 1973 |
[Determination of noradrenaline, of dopamine and dihydroxyphenylacetic acid in certain nuclei of rat brain].
Topics: Animals; Ascorbic Acid; Catecholamines; Caudate Nucleus; Chromatography, Thin Layer; Dihydroxyphenylalanine; Dopamine; Female; Fluorometry; Haloperidol; Hypothalamus; Male; Norepinephrine; Phenylacetates; Probenecid; Rats; Reserpine; Tranylcypromine | 1971 |
CSF GABA in psychotic disorders.
Topics: Adolescent; Adult; Female; gamma-Aminobutyric Acid; Haloperidol; Homovanillic Acid; Humans; Male; Middle Aged; Probenecid; Psychotic Disorders | 1980 |
Value of monoamine metabolite determinations in CSF as an index of their concentrations in rat brain following various pharmacological manipulations.
Topics: 5-Hydroxytryptophan; Animals; Biogenic Amines; Brain Chemistry; Catecholamines; Chromatography, High Pressure Liquid; Haloperidol; Indoles; Levodopa; Male; Probenecid; Rats; Rats, Inbred Strains; Time Factors | 1982 |
Endogenous kynurenic acid disrupts prepulse inhibition.
Topics: Acoustic Stimulation; Animals; Antipsychotic Agents; Brain; Brain Chemistry; Butyrates; Clozapine; Dopamine Antagonists; Dose-Response Relationship, Radiation; Drug Interactions; Haloperidol; Kynurenic Acid; Kynurenine; Male; Neural Inhibition; Probenecid; Rats; Reflex, Startle | 2004 |